Display options
Share it on

JACC CardioOncol. 2021 Dec 21;3(5):734-736. doi: 10.1016/j.jaccao.2021.11.004. eCollection 2021 Dec.

Risk of Myocardial Infarction in Patients Treated With 5-Fluorouracil: Balancing the Evidence With Black Boxes.

JACC. CardioOncology

Giorgio Minotti, Massimiliano Camilli

Affiliations

  1. Department of Medicine, University Campus Bio-Medico, Rome, Italy.
  2. Department of Medicine, Cardiovascular and Thoracic Sciences, Catholic University of the Sacred Heart, Rome, Italy.

PMID: 34988483 PMCID: PMC8702785 DOI: 10.1016/j.jaccao.2021.11.004

[No abstract available.]

Keywords: 5-fluorouracil; myocardial infarction; registry study; risk

Conflict of interest statement

The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

References

  1. Clin Colorectal Cancer. 2019 Mar;18(1):44-51 - PubMed
  2. Ther Adv Med Oncol. 2018 Jun 18;10:1758835918780140 - PubMed
  3. JACC CardioOncol. 2021 Mar;3(1):101-109 - PubMed
  4. Pharmacotherapy. 2011 Feb;31(2):226 - PubMed
  5. Cancer Treat Rev. 2021 Jul;98:102218 - PubMed
  6. Eur J Heart Fail. 2020 Dec;22(12):2290-2309 - PubMed
  7. J Am Heart Assoc. 2017 Aug 10;6(8): - PubMed
  8. Eur Heart J. 1991 Mar;12(3):468-70 - PubMed
  9. Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2727-37 - PubMed

Publication Types